Skip to content
10-Q

Quarterly Report

Oncolix, Inc.

0001477932-18-003888

← back to feed
Filed
Aug 9, 2018 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2018 · Aug 9, 2018 104.48M sh
Operating Cash Flow Q2 2018 · Jun 30, 2018 −$864.24K
Cash And Equivalents Q2 2018 · Jun 30, 2018 $578.7K
Cash And Equivalents Q2 2018 · Dec 31, 2017 $494.41K
Cash And Equivalents Q2 2018 · Jun 30, 2017 $93.38K
Stockholders Equity Q2 2018 · Jun 30, 2018 −$6.37M
Stockholders Equity Q2 2018 · Dec 31, 2017 −$1.64M
Current Liabilities Q2 2018 · Jun 30, 2018 $6.03M
Current Liabilities Q2 2018 · Dec 31, 2017 $1.26M
Total Liabilities Q2 2018 · Jun 30, 2018 $7.3M
Total Liabilities Q2 2018 · Dec 31, 2017 $2.53M
Current Assets Q2 2018 · Jun 30, 2018 $931.47K
Current Assets Q2 2018 · Dec 31, 2017 $889.4K
Total Assets Q2 2018 · Jun 30, 2018 $931.47K
Total Assets Q2 2018 · Dec 31, 2017 $889.4K
Sga Expense Q2 2018 · Jun 30, 2018 $298K
Sga Expense Q2 2018 · Jun 30, 2018 $593.82K
Rd Expense Q2 2018 · Jun 30, 2018 $63.57K
Rd Expense Q2 2018 · Jun 30, 2018 $167.9K
Rd Expense Q2 2018 · Jun 30, 2017 $26.78K
Rd Expense Q2 2018 · Jun 30, 2017 $77.1K
Net Income Q2 2018 · Jun 30, 2018 −$3.42M
Net Income Q2 2018 · Jun 30, 2018 −$4.92M